Veristat

Veristat is an established global contract research organization and consultancy specializing in the strategic planning and execution of clinical trials for novel therapies. With over three decades of experience and expertise in regulatory strategy, biometrics, medical writing, and full-service trial management—including support for the first gene therapy approved in Europe—Veristat enables biopharma sponsors to overcome complex development challenges. The company’s recent acquisition of SFL expanded its capabilities into market access and healthcare compliance within Europe. They are recognized for their work with rare diseases and biologics.